Antibiotic-resistant strains of Escherichia coli and, to a lesser extent, Klebsiella-Enterobacter were common in serial samples of the normal intestinal flora of healthy young adults in Thailand, and the resistance often was to multiple drugs and was transferable. Antibiotic administration promoted dominance of the flora by drug-resistant organisms regardless of the drug regimen and the predrug susceptibility pattern of the flora. The normal pattern was regained slowly after the cessation of drug administration.
In Thailand, pathogenic bacteria that are isolated from patients frequently contain an R factor(s) that confers resistance to multiple antibiotics (8) , and Escherichia coli strains with infectious drug resistance are commonly present in the fecal flora of healthy children (7) and adults (9) .
To study the dynamics of healthy carriage of drug-resistant enterobacteria, we obtained serial samples from the intestinal flora (rectal swab), the skin (hand washings in sterile saline), and the respiratory tract (throat swab) of 21 healthy young adults. Except for one participant who took tetracycline therapeutically for a brief period after a sample and ending 10 days before the next sample, the people received no antimicrobial agents during this portion of the study. Samples were cultivated on eosinmethylene blue agar (Difco). After growth, up to 20 colonies typical of E. coli and up to 15 colonies resembling Klebsiella-Enterobacter were isolated and identified by standard fermentation reactions (14) .
Each isolate was tested for susceptibility (9) first to 100 Ag of nalidixic acid/ml (SterlingWinthrop) in tryptic soy agar (TSA; Difco) and, if susceptible, then in TSA to 12.5 jg of each of the following/ml: ampicillin (Bristol Laboratories), chloramphenicol (Carlo Erba), kanamycin (Bristol Laboratories), neomycin (Roussel Uclaf), streptomycin (Hoechst), and tetracycline (Lederle Laboratories). Nalidixic acidresistant isolates, <0.05% of the total, were excluded. Because nearly all KlebsiellaEnterobacter strains resisted the test concentration of ampicillin, these results were also excluded. All other resistant organisms were tested once for capacity to transfer resistance (9) to an E. coli K-12 strain that (i) was free from known episomes, (ii) resisted 100 Mg of nalidixic acid/ml, and (iii) was susceptible to the other antibiotics tested. After growth of a test donor and the recipient as a mixed culture for 2 h, the recipient E. coli cells were first selected on TSA with 100 Mg of nalidixic acid/ml and then were tested as above for acquired resistance to the antibiotics that the donor resisted. Controls were a standard donor with the recipient, the recipient alone, and the test donor alone. The results with duplicate rectal swabs from five people demonstrated that both the proportion of drug-resistant E. coli cells and the pattern of drug susceptibility were similar in the two samples. Therefore, a single sample was processed at each collection. In 8 to 11 weekly or biweekly samples during 15 to 17 weeks (Table 1 ), E. coli strains that resisted one or more of the drugs were (i) recovered from the fecal flora of each person at some time, (ii) present in a majority of the fecal samples from the individuals, and (iii) recovered from 86% of the total fecal samples (182 of 211). Resistant E. coli strains comprised > 50% of the fecal E. coli isolates in at least one VOL. 4, 1973 sample from most of the people (Table 1 ) and in 23% of all samples (48 of 211). The samples frequently contained E. coli strains that resisted more than one of the drugs (126 of 211 samples, 60%) and that could transfer drug resistance (122 of 211 samples, 58%). Of the 3,142 isolates of E. coli that were tested in this portion of the study (Table 2) , 31% resisted at least one of the drugs, 15% resisted more than one of the drugs, and 12% transmitted resistance. Resistance was most common to tetracycline (27% of total isolates) followed by streptomycin (16%), ampicillin (6%), chloramphenicol (5%), and kanamycin (1%) and neomycin (1%).
Klebsiella-Enterobacter strains were recovered from the fecal flora less often than E. coli strains (Table 1) . A majority of the persons had drug-resistant Klebsiella-Enterobacter strains in the feces at some time; most of these individuals carried the drug-resistant organisms only occasionally. Of the 189 samples, Klebsiella-Enterobacter strains were recovered that resisted one or more drug from 31 (16%), that resisted more than one drug from 18 (10%), and that transferred resistance from 23 (12%). A small proportion of the total isolates of Klebsiella-Enterobacter resisted drugs and transferred resistance (Table 2) . Resistance was mainly to tetracycline and, to a lesser extent, to streptomycin.
Occasionally, a few E. coli cells were recovered from the respiratory tract (1 sample from three different people) and a few Klebsiella-Enterobacter cells were recovered from the skin (five samples from four people) and respiratory tract (13 samples from four people); E. coli was not recovered from the respiratory tract. Except for one isolate of E. coli that re- sisted tetracycline, the extraintestinal isolates of both organisms were susceptible to the drugs used here. The effect of antibiotic administration on the healthy carriage of E. coli and KlebsiellaEnterobacter was assessed in 20 of the people who volunteered to take antibiotics; they were randomly divided into four groups of five, and each group was assigned to one of the following regimens of orally administered antibiotics: (i) ampicillin, 250 mg thrice daily; (ii) neomycin, 250 mg thrice daily; (iii) tetracycline, 250 mg four times daily; or (iv) both neomycin and tetracycline in the above daily doses. Sampling was conducted as before at 3 and 5 days of administration and at 3 days and 1, 2, 3, and 4 weeks after administration of the antibiotics. By 3 days after the start of the drug, the volunteers uniformly had drug-resistant E. coli cells in their fecal flora, and all of the E. coli isolates were drug-resistant regardless of the drug regimen and the drug-susceptibility patterns of the fecal E. coli isolates before the drug. The E. coli strains resisted the drug(s) consumed and, commonly, three to five of the other drugs. Most isolates transferred resistance in the single test of transfer capacity. This pattern persisted for a variable time after drug administration, but gradually the members of each of the groups regained a pattern typical of the subjects in the predrug period. The return to the typical "normal" pattern was similar in the four groups and required 3 to 4 weeks.
The effect of antibiotic consumption on the Klebsiella-Enterobacter strains of the intestinal flora resembled that on E. coli. During drug administration, Kle bsiella-Enterobacter strains with infectious multiple drug resistance dominated the Klebsiella-Enterobacter flora regardless of the drug(s) administered and the susceptibility of the predrug flora. The typical "normal" pattern was gradually restored after cessation of the drug regimen. (2, 6, 10, 11, 16) . In further contrast to the results in Thailand, the proportion of drug-resistant organisms in the fecal E. coli flora was low, exceeding 10% in only 20% of people (6) . A recent study from the United States described drug resistance in 54% of E.coli isolates from healthy students (1) . A prevalence of 78% in an urban population in South Africa (13) approximates the present results. In the above and the present studies, the pattern of drug resistance was similar: frequently multiple, often transferable, and involving tetracycline and streptomycin most commonly. The prevalence of drug-resistant Klebsiella-Enterobacter strains seems low generally (e.g., 4). Resistance to ampicillin is common, as noted herein, and such resistance is often not transferable. The KlebsiellaEnterobacter isolates most commonly resist streptomycin and tetracycline among other antibiotics.
Among factors that may contribute to the rapid circulation of drug-resistant enterobacteria in the population in Thailand and other areas of high prevalence are (i) heavy environmental contamination by fecal organisms, e.g., in foods and water (17) , (ii) crowded living conditions, and (iii) the constant and strong selective pressure exerted through widespread usage of antibiotics both by prescription and by ready availability "over the counter." The impact of great antibiotic usage is emphasized by the results of antibiotic administration and also by the striking contrast in the prevalence of ANTIMICROB. AG. CHEMOTHER. drug-resistant fecal E. coli isolates between drug-using (above) and drug-free societies, e.g., 3% in Borneo (3), 5% in the Solomon Islands (5), and 19% in South Africa (12)-areas in which fecal contamination of food and waters is probably high.
